LON:REDX Redx Pharma (REDX) Share Price, News & Analysis GBX 15 +3.60 (+31.58%) (As of 04/30/2024) Add Compare Share Share Today's Range 11.42▼ 3350-Day Range 15▼ 1552-Week Range 4▼ 37.90Volume1.42 million shsAverage Volume707,637 shsMarket Capitalization£58.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Redx Pharma alerts: Email Address Ad Deal MakerThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.Learn more about this much-needed advancement and investment opportunity here. About Redx Pharma Stock (LON:REDX)Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating fibrotic disease, cancer, and the emerging area of cancer-associated fibrosis in the areas of unmet medical needs. The company also develops zelasudil (RXC007), a selective rho associated coiled-coil containing protein kinase 2 (ROCK2) inhibitor, which is in Phase 2 clinical trial for the treatment of multiple interstitial lung diseases and cancer-associated fibrosis; RXC008, a potential first-in-class GI-targeted ROCK inhibitor that is in preclinical studies for the treatment of fibrostenotic Crohn's disease; and zamaporvint (RXC004), a porcupine inhibitor that is in Phase 2 clinical trial for targeted therapy of Wnt-ligand dependent cancers. In addition, it is developing RXC009, a potent and selective DDR1 inhibitor, which is in preclinical studies for the treatment of chronic kidney disease; Kirsten rat sarcoma virus (KRAS) inhibitor to target G12D selective and multi-KRAS profiles; RXC006/AZD5055 a porcupine inhibitor, which is in Phase 1 clinical trial for targeting fibrotic diseases, including idiopathic pulmonary fibrosis; JZP815, a pan-rapidly accelerated fibrosarcoma inhibitor that is in Phase 1 clinical trial to overcome resistance mechanisms associated with clinically approved B-RAF selective drugs; and mitogen-activated protein kinase pathway targets for oncology indications. The company has research collaboration agreements with Jazz Pharmaceuticals plc to develop JZP815, as well as discovery and preclinical development of a targeted cancer therapy on the Ras/RAF/MAP kinase pathway; and AstraZeneca plc to develop RXC006/AZD5055, a Porcupine inhibitor for the treatment of fibrotic disease. Redx Pharma Plc was incorporated in 2010 and is based in Macclesfield, the United Kingdom.Read More REDX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart REDX Stock News HeadlinesJuly 23, 2024 | msn.comBUSINESS LIVE: BT fined over 999 failings; Entain names CEO; UK dividends hit record highMay 1, 2024 | markets.businessinsider.comRedx Pharma Plc Shares now trading on JP JenkinsSeptember 7, 2024 | Porter & Company (Ad)The death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.April 20, 2024 | msn.comRedx boss scooped up shares after revealing London Stock Exchange exitApril 13, 2024 | morningstar.comRedx Pharma PLC REDXApril 13, 2024 | thetimes.co.ukExodus from Aim leaves chorus of questions in its wakeApril 10, 2024 | msn.comLondon markets are broken and closed, says pharma bossApril 10, 2024 | msn.comIs the London Stock Exchange’s AIM in terminal decline?September 7, 2024 | Porter & Company (Ad)The death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.April 7, 2024 | ft.comThe Lex Newsletter: The UK has a two-speed market problemApril 3, 2024 | ft.comDo not blame London for this latest stock market departureApril 2, 2024 | thetimes.co.ukRedX Pharma blames finance constraints for quitting stock marketApril 2, 2024 | msn.comPharma Redx is latest firm to delist from AIMApril 2, 2024 | uk.investing.comSterling ticks up as UK manufacturing recoversApril 2, 2024 | lse.co.ukAIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delistApril 2, 2024 | msn.comLondon loses another listed company as pharma riser goes privateApril 2, 2024 | msn.comFTSE 100 Live 2 April: Blue-chips in surprise jump to top 8000, near record high; house prices dip in MarchApril 2, 2024 | lse.co.ukRedx Pharma plummets on plans to delist from AIMSee More Headlines Receive REDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Redx Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/19/2018Today9/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:REDX CUSIPN/A CIKN/A Webredxpharma.com Phone+44-151-7064747FaxN/AEmployees101Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-33,160,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-180.80% Return on Assets-43.95% Debt Debt-to-Equity Ratio527.00 Current Ratio1.11 Quick Ratio1.93 Sales & Book Value Annual Sales£4.20 million Price / Sales13.89 Cash FlowGBX 2.87 per share Price / Cash Flow5.23 Book ValueGBX 1 per share Price / Book15.00Miscellaneous Outstanding Shares388,990,000Free FloatN/AMarket Cap£58.35 million OptionableNot Optionable Beta-0.53 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMs. Lisa Mary Whewell Anson (Age 56)CEO & Executive Director Comp: $608.13kMr. Peter J. CollumChief Financial OfficerDr. James Mead (Age 46)Chief Operating Officer Comp: $132.67kDr. Richard ArmerChief Scientific OfficerDr. Karl Hard Ph.D. (Age 62)Head of Investor Relations Ms. Claire Penelope SolkGeneral Counsel & Company SecretaryMs. Caitlin PearsonHead of CommunicationsDr. Cliff JonesSenior Vice President of Chemistry, DMPK & Intellectual PropertyDr. Caroline PhillipsSenior Vice President of BiologyMr. Craig TilstonHead of Development OperationsMore ExecutivesKey CompetitorsVerona Pharma plc (VRP.L)LON:VRPFaron Pharmaceuticals OyLON:FARNBioventixLON:BVXPhVIVOLON:HVO4basebioLON:4BBView All CompetitorsInsidersLisa AnsonBought 115,000 shares on 4/16/2024Total: £1.04 M ($9.00/share)Lisa AnsonBought 399,000 shares on 4/11/2024Total: £3.19 M ($8.00/share) REDX Stock Analysis - Frequently Asked Questions How have REDX shares performed this year? Redx Pharma's stock was trading at GBX 22 at the beginning of the year. Since then, REDX shares have decreased by 31.8% and is now trading at GBX 15. View the best growth stocks for 2024 here. How were Redx Pharma's earnings last quarter? Redx Pharma Plc (LON:REDX) released its quarterly earnings data on Monday, November, 19th. The company reported ($7.00) earnings per share (EPS) for the quarter, missing the consensus estimate of ($6.50) by $0.50. How do I buy shares of Redx Pharma? Shares of REDX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Redx Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Redx Pharma investors own include Digital Globe Services (DGS), OptiBiotix Health (OPTI), TLA Worldwide (TLA), Be Heard Group plc (BHRD.L) (BHRD), Salesforce (CRM), Carnival Co. & (CCL). This page (LON:REDX) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Redx Pharma Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Redx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.